Entries in Aging (7)


Our New Special Issue in IOVS

Read more here: Press Release

This issue made possible by the generous support from


June 2013 Symposium: The Aging Eye

Photos: Dyanne Cano and Jonathan Furukawa


Our Upcoming Symposium on The Aging Eye

We are very excited to hold our upcoming 8th symposium later this week on the following topic:

The Aging Eye:
Normal Changes, Age-Related Diseases and Sight-Saving Approaches
Terranea Resort, Rancho Palos Verdes, CA
June 14-16, 2013

Led by co-chairs Dr. Gerald Chader of the Doheny Eye Institute and Dr. Allen Taylor of Tufts University, this symposium promises to be engaging and dynamic, as 15 of the field's top researchers and doctors in eye research will meet for two days to discuss recent findings and breakthroughs in diseases and conditions affecting the aging eye.


  • Dr. Catherine Bowes-Rickman – Department of Ophthalmology, Duke University Medical Center 
  • Dr. David Calkins – Vanderbilt Eye Center, Vanderbilt University Medical Center
  • Dr. Joseph Caprioli – Jules Stein Eye institute, UCLA
  • Dr. Gerald Chader – Doheny Retina Institute, USC School of Medicine
  • Dr. Emily Chew – Epidemiology & Clinical Applications, National Eye Institute, National Institutes of Health 
  • Dr. Gislin Dagnelie – Department of Ophthalmology. Johns Hopkins Hospital 
  • Dr. Ilene Gipson – Schepens Eye Research Institute, Massachusetts Eye & Ear Infirmary, Harvard School of Medicine 
  • Dr. Hans Grossniklaus – Department of Ophthalmology, School of Medicine, Emory University
  • Dr. Barbara Klein – Department of Ophthalmology & Visual Sciences, University of Wisconsin-Madison 
  • Dr. Ronald Klein – Department of Ophthalmology & Visual Sciences, University of Wisconsin School of Medicine & Public Health 
  • Dr. Gerard Lutty – Wilmer Eye Institute, Johns Hopkins University School of Medicine 
  • Dr. J. Mark Petrash – Department of Ophthalmology, University of Colorado, Denver 
  • Dr. David Rein – National Organization for Research at the University of Chicago
  • Dr. Johanna Seddon – Department of Ophthalmology, Tufts University School of Medicine 
  • Dr. Allen Taylor – Nutrition & Vision Research, USDA-HNRCA, Tufts University
  • Friday

    New Link Between Glucosamine and Glaucoma

    Image courtesy of wisegeek.com

    A new link between the oral supplement, glucosamine, and glaucoma has been found in a new, small study published as aresearch letter in The Journal of the American Medical Association. The study was done with 17 participants all over the age of 76.

    Specifically, the study found:

    Overall, pressure inside the eye was higher when participants were taking glucosamine, but did return to normal after they stopped taking these supplements, the study showed.

    "This study shows a reversible effect of these changes, which is reassuring," wrote researchers led by Dr. Ryan Murphy at the University of New England College of Osteopathic Medicine in Biddeford, Maine. "However, the possibility that permanent damage can result from prolonged use of glucosamine supplementation is not eliminated. Monitoring IOP in patients choosing to supplement with glucosamine may be indicated."

    U.S. News and World Report noted that while this was the first time this link has been made, the study was limited in terms of brand and duration of the supplement. 

    Read the Research Letter: Oral Glucosamine Supplements as a Possible Ocular Hypertensive Agent

    Read the U.S. News and World Report Article: Glucosamine Supplements Tied to Risk of Eye Condition


    The Economic Costs of Age-Related Eye Disease

    Image courtesy of wfsb.com

    The American Journal of Managed Care published an online supplement by William J. Cardarelli, PharmD and Roderick A. Smith, MS discussing the current economic effects and costs of eye disease as it related to our aging population in the U.S. Areas covered include Open-Angle Glaucoma, Wet AMD, and Dry Eye Disease.

    The authors concluded the following:

    The trend of rising costs associated with visual impairment and the treatment of age-related ocular diseases in the United States is having a tremendous impact on patients’ caregivers, third-party payers, and society. These costs will almost certainly continue to increase in the coming decades as the baby boomer generation reaches old age. While new treatments for eye diseases are benefiting thousands of patients, the costs of these treatments are a major cause of concern.

    Read the Article: Managed Care Implications of Age-Related Ocular Conditions


    ORSF Symposium's Emily Chew Discusses Her New Study

    Image courtesy of the US National Library of MedicineImage courtesy of shape.com








    ORSF is honored to have Emily Y. Chew, MD, of the National Eye Institute (NEI) participate in our June 2013 Symposium on the Aging Eye. She recently published a study in the Journal of the American Medical Association on supplements and macular degeneration. 

    Some of the findings included:

    To probe whether the addition of lutein, zeaxanthin, and omega-3 long-chain polyunsaturated fatty acids to the currently recommended supplement offers benefit, the AREDS team conducted a randomized study of 1608 participants comparing progression of macular degeneration among individuals taking the original supplement plus lutein, zeaxanthin, and omega-3 fatty acids or the original supplement plus placebo. They did not find any additional reductions in progression in the group receiving the add-on supplementation. They did, however, find that former smokers taking the original supplement (current smokers were excluded from groups receiving beta carotene) had an increased rate of lung cancer compared with those taking a revised version of the original supplement that substituted lutein and zeaxanthin for beta carotene.

    JAMA conducted a Q & A with Dr. Chew about her study. Read it here.


    Weinberg Foundation's Aging Initiative Findings

    Image courtesy of University of Kentucky

    As our upcoming 2013 symposium is on the aging eye, the Weinberg Foundation's findings from its aging initiative are relevant to the overall topic of aging in the US.

    "Launched in 2009, the three-year, $15 million effort set out to identify the benefits of and best practices with respect to supporting family and informal caregivers, who provide as much as 80 percent of all long-term care for the chronically ill and disabled."

    Read the article: Weinberg Foundation Announces Findings of Aging Initiative

    Read the 20 page analysis: "The Weinberg Caregiver Initiative"